Animal Stem Cell Therapy Market
Animal Stem Cell Therapy Market Study by Hemopoietic and Mesenchymal Stem Cells for Osteoarthritis, Soft Tissue Injuries, Fractures, Tendonitis, and Inflammatory Bowel Disease from 2024 to 2034
Analysis of Animal Stem Cell Therapy Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Animal Stem Cell Therapy Market Outlook (2024 to 2034)
The global animal stem cell therapy market size has been estimated at US$ 290.5 million for 2024 and is forecasted to expand at a CAGR of 5% and reach a size of US$ 474.8 million by the end of 2034.
Animal stem cell therapy involves the use of stem cells derived from animals, typically the patient's own body (autologous) or from a compatible donor (allogeneic), for therapeutic purposes. Stem cells are undifferentiated cells with the unique ability to differentiate into various cell types and replicate to form new tissues. In the context of veterinary medicine, this therapy is applied to treat various medical conditions and injuries in animals.
The process usually involves the extraction of stem cells from the animal's body, commonly from sources such as bone marrow, adipose tissue (fat), or other tissues. These cells are then processed and prepared for injection or implantation back into the animal. Once administered, stem cells can promote tissue repair and regeneration, reduce inflammation, and modulate the immune system, among other potential therapeutic effects.
In North America, growing awareness of the potential benefits of animal stem cell therapy among pet owners and veterinarians is significantly contributing to its growing demand.
- North America is expected to hold 30.6% of global animal stem cell therapy market share in 2024.
In East Asia, the growing pet ownership culture, particularly in countries such as China and Japan, is leading to a substantial uptick in demand for innovative veterinary treatments, including animal stem cell therapies.
- Animal stem cell therapy market growth in East Asia is forecasted at a CAGR of 6% from 2024 to 2034.
Hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) are two distinct types of stem cells with different functions and potential applications in medical research and therapies.
- Revenue from MSC-based therapies is projected to reach US$ 345 million by 2034-end, advancing at a CAGR of 5.2%.
MSCs differentiate into various cell types, including bone, cartilage, and adipose tissue. This versatility makes them attractive for a wide range of therapeutic applications, from regenerative medicine to tissue repair.
Regenerative properties of MSCs promote the repair and regeneration of damaged tissues. This characteristic is particularly valuable in the treatment of conditions involving injury, inflammation, or degeneration, such as orthopedic disorders and autoimmune diseases. Thus, all these factors are boosting the popularity of mesenchymal stem cell-based therapies.
| Report Attributes | Details |
|---|---|
| Animal Stem Cell Therapy Market Size (2024E) | US$ 290.5 Million |
| Forecasted Market Value (2034F) | US$ 474.8 Million |
| Global Market Growth Rate (2024 to 2034) | 5% CAGR |
| North America Market Growth Rate (2024 to 2034) | 5.4% CAGR |
| East Asia Market Share (2034F) | 13.7% |
| Allogeneic Segment Share (2034F) | 63.4% |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
How is Growing Trend of Pet Humanization Influencing Demand for Stem Cell Therapy?
“Growing Pet Ownership Stimulating Demand for Cutting-Edge Treatment Options”
Pet owners nowadays view their animals as integral members of their family, fostering a deep emotional connection. This shift in perception is elevating the importance of ensuring the overall well-being and health of pets, mirroring the care and attention typically reserved for human family members.
With the proliferation of information through various channels, including social media and online platforms, pet owners are more informed about health-related issues affecting animals. This growing awareness is leading to a proactive approach, where pet owners actively seek preventive and therapeutic measures to address potential health concerns.
Surge in pet ownership worldwide, coupled with the evolving trend of humanization of pets, is profoundly influencing the demand for advanced healthcare options, with a notable emphasis on cutting-edge treatments such as stem cell therapy.
“Increasing Focus on Providing Enhanced Quality of Life for Pets”
Adoption of regenerative therapies, notably stem cell therapy, as a preferred treatment option for various ailments in companion animals is a prominent and evolving trend. This shift is driven by a combination of factors, reflecting the changing landscape of veterinary care and the increasing demand among pet owners for advanced and innovative solutions to enhance the health and well-being of their cherished pets.
With the aging pet population, there is a noticeable increase in the prevalence of chronic conditions such as osteoarthritis, degenerative joint diseases, and other musculoskeletal issues. Regenerative therapies, particularly stem cell therapy, offer a promising avenue for addressing these conditions by promoting tissue repair and reducing inflammation.
Pet owners are increasingly inclined towards non-invasive and minimally traumatic treatment options for their animals. Regenerative therapies, characterized by their targeted and minimally invasive nature, align with this preference, thus providing an alternative to more invasive surgical procedures.
Modern pet ownership ethos places a strong emphasis on ensuring the highest possible quality of life for companion animals. Regenerative therapies, including stem cell therapy, are perceived as interventions that go beyond merely treating symptoms. They are seen as contributors to a holistic approach to veterinary care, aiming to enhance an animal's overall well-being.
What are the Constraints That Animal Stem Cell Solution Providers Face?
“High Animal Stem Cell Treatment Coss Limiting Widespread Adoption”
While demand for animal stem cell therapy is on the rise, affordability remains a critical factor impacting its widespread adoption. The relatively high cost associated with animal stem cell therapy is limiting its widespread adoption. Affordability concerns among pet owners and farmers in some regions may hinder market growth.
In many regions, pet insurance coverage for regenerative therapies, including stem cell therapy, is limited. The absence of comprehensive insurance coverage places the financial burden squarely on pet owners and farmers, making it a significant factor in their decision-making process.
Limited awareness and training among some veterinarians regarding the benefits and application of stem cell therapy is also acting as a barrier to market growth. Efforts to enhance education and training in veterinary schools and clinics are essential for overcoming this restraint. This situation is mostly observed in poor and developing regions, where skilled medical staff and advanced healthcare infrastructure for pets and farm animals are very rarely available.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How are Start-ups Penetrating the Field of Animal Stem Cell Therapy?
“Strategic Partnerships Aiding New Companies in Enhancing Their Product Portfolio”
Entering the animal stem cell therapy market as a newcomer can be challenging, but adopting strategic moves can aid in getting profitable rewards. To maximize earnings, new companies should strategically navigate various aspects of the market.
New companies should forge strategic collaborations and partnerships with established players in the veterinary and biotechnology industries. This can provide access to valuable resources, including expertise, distribution networks, and existing customer bases. Collaborative ventures can also enhance credibility and facilitate knowledge transfer.
New companies can prioritize investments in research and development initiatives to differentiate products or services. Innovations in stem cell technology, treatment protocols, and ancillary products can set newcomers apart in a rapidly advancing field. Demonstrating a commitment to advancing science can attract both customers and industry attention.
Country-wise Analysis
Animal stem cell therapy market trends are affected by a combination of factors specific to each country. Rising pet ownership, advanced veterinary infrastructure, research and development initiatives, and cultural attitudes toward pet care are contributing to the demand for animal stem cell therapy in the United States, Germany, and Japan.
What is Boosting Demand for Animal Stem Cell Therapy Products in the United States?
“Rising Pet Ownership and Growing Awareness of Animal Stem Cell Therapy”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 72.7 Million |
| Growth Rate (2024 to 2034) | 5.6% CAGR |
| Projected Value (2034F) | US$ 125.5 Million |
The United States is experiencing a surge in pet ownership, with an increasing number of households adopting companion animals. This trend is further fueled by the humanization of pets, where owners consider them as family members, driving the demand for advanced healthcare options including stem cell therapy to enhance their pet's quality of life.
There is an increasing awareness among pet owners in the United States regarding the benefits of stem cell therapy. This growing awareness, facilitated by access to information through online platforms, veterinary literature, and awareness campaigns is empowering pet owners to actively seek out regenerative treatments for their animals, thus driving market growth.
Why is Germany a Lucrative Market for Animal Stem Cell Therapy Providers?
“Advancements in Veterinary Medicine Leading to Improved Regenerative Therapies”
Germany is at the forefront of technological advancements in veterinary medicine. The country's veterinary practices leverage cutting-edge technology, creating an environment conducive to the integration of regenerative therapies. The intersection of technological innovation and veterinary care promotes the adoption of animal stem cell therapy.
A strong culture of pet care, with a significant portion of households owning pets, is influencing market growth. German pet owners are increasingly inclined to explore advanced therapies, including stem cell treatments, as part of comprehensive pet healthcare.
Will Japan Be a Profitable Market for Animal Stem Cell Therapy Product Suppliers?
“High Willingness of People to Invest in Premium Pet Healthcare”
| Attribute | Japan |
|---|---|
| Market Value (2024E) | US$ 18 Million |
| Growth Rate (2024 to 2034) | 6.7% CAGR |
| Projected Value (2034F) | US$ 34.2 Million |
Japan's growing affluence is leading to an increase in pet ownership, particularly among urban households. With a rising middle class willing to invest in premium pet care, there is a growing demand for advanced healthcare solutions, with animal stem cell therapy gaining traction as a preferred option.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Analysis
As per the detailed study by Fact.MR, a market research and competitive intelligence provider, the increasing demand for autologous-sourced animal stem cell therapies is driven by its safety profile, avoidance of immune reactions, individualized treatment approach, ethical considerations, and enhanced therapeutic potential. These factors are collectively contributing to the growing popularity of autologous stem cell therapy in veterinary medicine.
Which Source is Popular for Animal Stem Cell Therapy?
“Autologous Animal Stem Cell Therapy Reducing Risk of Rejection and Reaction”
| Attribute | Autologous Animal Stem Cell Therapy |
|---|---|
| Segment Value (2024E) | US$ 100 Million |
| Growth Rate (2024 to 2034) | 5.7% CAGR |
| Projected Value (2034F) | US$ 174 Million |
Autologous refers to a medical procedure or treatment in which a patient's cells or tissues are used for therapeutic purposes. In the context of animal treatment, autologous stem cell therapy involves harvesting and utilizing an individual animal's stem cells for therapeutic applications. This is in contrast to allogeneic stem cell therapy, where stem cells from a donor animal are used.
Since the cells are derived from the same animal, autologous stem cell therapy eliminates the risk of rejection or adverse reactions. This is particularly significant in veterinary medicine, where ensuring the safety of the treatment is paramount.
Competitive Landscape
Key players in the animal stem cell therapy industry are investing significantly in research and development initiatives to advance stem cell technologies and develop innovative therapies. This includes exploring new applications, improving treatment protocols, and enhancing the overall efficacy of animal stem cell therapy. Introduction of cutting-edge therapies is aiding in attracting a broader customer base and establishing market leadership.
- In 2019, Medrego unveiled a groundbreaking stem cell therapy solution dedicated to enhancing the health and vitality of dogs. Introducing CaniCell, a cutting-edge product specifically designed for the treatment of conditions such as osteoarthritis and various degenerative diseases prevalent in canine companions.
Key Segments of Animal Stem Cell Therapy Market Research
-
By Product Type :
- Hemopoietic Stem Cells
- Mesenchymal Stem Cells
-
By Source :
- Allogeneic
- Autologous
-
By Application :
- Osteoarthritis
- Soft Tissue Injuries
- Traumatic Fractures
- Tendonitis
- Inflammatory Bowel Disease
- Others
-
By Species :
- Canine
- Feline
- Equine
-
By End User :
- Veterinary Hospitals
- Veterinary Clinics
- Veterinary Research Institutes
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Type Innovation / Development Trends 4. Market Background 4.1. Macro-Economic Factors 4.1.1. Rise in Expenditure 4.1.2. Increased Per Capita Expenditure 4.2. Forecast Factors - Relevance & Impact 4.2.1. Product Type in Pipeline 4.2.2. Regulatory Scenario 4.2.3. Mergers and Acquisitions 4.2.4. Collaborative Agreements 4.2.5. Value Chain 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunity Analysis 4.4. COVID19 Crisis Analysis 4.4.1. Current COVID19 Statistics and Probable Future Impact 4.4.2. Current GDP Projection and Probable Impact 4.4.3. Current Economic Projection as Compared to 2008 Economic analysis 4.4.4. COVID19 and Impact Analysis 4.4.4.1. Revenue By Product Type 4.4.4.2. Revenue By Application 4.4.4.3. Revenue By Source 4.4.4.4. Revenue By Species 4.4.4.5. Revenue By End User 4.4.4.6. Revenue By Country 4.4.5. 2020 Market Scenario 4.4.6. Quarter by Quarter Forecast 4.4.7. Projected Recovery Quarter 4.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact 5. Market Context 5.1. Adoption and Usage Analysis 5.2. Market Evolution 5.3. Product Type Vs Application Matrix 5.4. Regulatory Scenario 5.5. Parent Market Analysis 5.6. Key Promotional Strategies by Market Players 6. Global Market - Pricing Analysis 6.1. Regional Pricing Analysis By Product Type 6.2. Pricing Break-up 6.2.1. Manufacturer Level Pricing 6.2.2. Distributor Level Pricing 6.3. Global Average Pricing Analysis Benchmark 7. Global Market Value Analysis 2018 to 2023 and Forecast, 2024 to 2034 7.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2023 7.2. Current and Future Market Value (US$ Mn) Projections, 2024 to 2034 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Product Type 8.1. Introduction / Key Findings 8.2. Historical Market Species (US$ Mn) Analysis By Product Type, 2018 to 2023 8.3. Current and Future Market Species (US$ Mn) Analysis and Forecast By Product Type, 2024 to 2034 8.3.1. Hemopoietic Stem Cells 8.3.2. Mesenchymal Stem Cells 8.4. Market Attractiveness Analysis By Product Type 9. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Allogeneic 10. Autologous 10.1. Introduction / Key Findings Source Species, 2018 to 2023 10.2. Current and Future Market Species (US$ Mn) Analysis and Forecast By Source, 2024 to 2034 10.2.1. Organic Animal Stem Cell Therapy 10.2.2. Conventional Animal Stem Cell Therapy 10.3. Market Attractiveness Analysis By Source 11. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Application 11.1. Introduction / Key Findings Application Species, 2018 to 2023 11.2. Current and Future Market Species (US$ Mn) Analysis and Forecast By Application, 2024 to 2034 11.2.1. Osteoarthritis 11.2.2. Soft Tissue Injuries 11.2.3. Traumatic Fractures 11.2.4. Tendonitis 11.2.5. Inflammatory Bowel Disease 11.2.6. Others 11.3. Market Attractiveness Analysis By Application 12. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Species 12.1. Introduction / Key Findings Species, 2018 to 2023 12.2. Current and Future Market Species (US$ Mn) Analysis and Forecast By Species, 2024 to 2034 12.2.1. Canine 12.2.2. Feline 12.2.3. Equine 12.3. Market Attractiveness Analysis By Species 13. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by End User 13.1. Introduction / Key Findings 13.2. Historical Market Species (US$ Mn) Analysis By End User, 2018 to 2023 13.3. Current and Future Market Species (US$ Mn) Analysis and Forecast By End User, 2024 to 2034 13.3.1. Veterinary Hospitals 13.3.2. Veterinary Clinics 13.3.3. Veterinary Research Institutes 13.4. Market Attractiveness Analysis By End User 14. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region 14.1. Introduction 14.2. Historical Market Species (US$ Mn) Analysis By Region, 2018 to 2023 14.3. Current Market Species (US$ Mn) Analysis and Forecast By Region, 2024 to 2034 14.3.1. North America 14.3.2. Latin America 14.3.3. Europe 14.3.4. East Asia 14.3.5. South Asia 14.3.6. Oceania 14.3.7. Middle East and Africa (MEA) 14.4. Market Attractiveness Analysis By Region 15. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034 15.1. Introduction 15.2. Historical Market Species (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 15.3. Market Species (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 15.3.1. By Country 15.3.1.1. United States 15.3.1.2. Canada 15.3.2. By Product Type 15.3.3. By Source 15.3.4. By Application 15.3.5. By Species 15.3.6. By End User 15.4. Market Attractiveness Analysis 15.5. Market Trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 16. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034 16.1. Introduction 16.2. Historical Market Species (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 16.3. Market Species (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. Italy 16.3.1.3. France 16.3.1.4. United Kingdom 16.3.1.5. Spain 16.3.1.6. Rest of Europe 16.3.2. By Product Type 16.3.3. By Source 16.3.4. By Application 16.3.5. By Species 16.3.6. By End User 16.4. Market Attractiveness Analysis 16.5. Market Trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 17. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034 17.1. Introduction 17.2. Historical Market Species (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 17.3. Market Species (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 17.3.1. By Country 17.3.1.1. GCC Countries 17.3.1.2. South Africa 17.3.1.3. Rest of Middle East and Africa 17.3.2. By Product Type 17.3.3. By Source 17.3.4. By Application 17.3.5. By Species 17.3.6. By End User 17.4. Market Attractiveness Analysis 17.5. Market Trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 18. Rest of the World Market Analysis 2018 to 2023 and Forecast 2024 to 2034 18.1. Introduction 18.2. Historical Market Species (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2023 18.3. Market Species (US$ Mn) Forecast By Market Taxonomy, 2024 to 2034 18.3.1. By Product Type 18.3.2. By Source 18.3.3. By Application 18.3.4. By Species 18.3.5. By End User 18.4. Market Attractiveness Analysis 18.5. Market Trends 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 19. Key and Emerging Countries Market Analysis 2018 to 2023 and Forecast 2024 to 2034 19.1. Introduction 19.1.1. Market Value Proportion Analysis, By Key Countries 19.1.2. Global Vs. Country Growth Comparison 19.2. United States Market Analysis 19.2.1. By Product Type 19.2.2. By Source 19.2.3. By Application 19.2.4. By Species 19.2.5. By End User 19.3. Canada Market Analysis 19.3.1. By Product Type 19.3.2. By Source 19.3.3. By Application 19.3.4. By Species 19.3.5. By End User 19.4. United Kingdom Market Analysis 19.4.1. By Product Type 19.4.2. By Source 19.4.3. By Application 19.4.4. By Species 19.4.5. By End User 19.5. Germany Market Analysis 19.5.1. By Product Type 19.5.2. By Source 19.5.3. By Application 19.5.4. By Species 19.5.5. By End User 19.6. France Market Analysis 19.6.1. By Product Type 19.6.2. By Source 19.6.3. By Application 19.6.4. By Species 19.6.5. By End User 19.7. Italy Market Analysis 19.7.1. By Product Type 19.7.2. By Source 19.7.3. By Application 19.7.4. By Species 19.7.5. By End User 19.8. Spain Market Analysis 19.8.1. By Product Type 19.8.2. By Source 19.8.3. By Application 19.8.4. By Species 19.8.5. By End User 19.8.6. By End User 19.9. GCC Countries Market Analysis 19.9.1. By Product Type 19.9.2. By Source 19.9.3. By Application 19.9.4. By Species 19.9.5. By End User 19.10. South Africa Market Analysis 19.10.1. By Product Type 19.10.2. By Source 19.10.3. By Application 19.10.4. By Species 19.10.5. By End User 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Concentration 20.3. Market Share Analysis of Top Players 20.4. Market Presence Analysis 20.4.1. By Regional footprint of Players 20.4.2. Product Type foot print by Players 20.4.3. Channel Foot Print by Players 21. Competition Analysis 21.1. Competition Dashboard 21.2. Competition Benchmarking 21.3. Competition Deep Dive 21.3.1. Aratana Therapeutics, Inc. 21.3.1.1. Overview 21.3.1.2. Product Type Portfolio 21.3.1.3. Analyst Commentary 21.3.1.4. Key Financials 21.3.1.5. Recent Developments 21.3.1.6. Sales Footprint 21.3.1.7. Strategy Overview 21.3.1.7.1. Marketing Strategy 21.3.1.7.2. Product Type Strategy 21.3.1.7.3. Channel Strategy 21.3.2. VetStem, Inc. 21.3.2.1. Overview 21.3.2.2. Product Type Portfolio 21.3.2.3. Analyst Commentary 21.3.2.4. Key Financials 21.3.2.5. Recent Developments 21.3.2.6. Sales Footprint 21.3.2.7. Strategy Overview 21.3.2.7.1. Marketing Strategy 21.3.2.7.2. Product Type Strategy 21.3.2.7.3. Channel Strategy 21.3.3. Regeneus Ltd. 21.3.3.1. Overview 21.3.3.2. Product Type Portfolio 21.3.3.3. Analyst Commentary 21.3.3.4. Key Financials 21.3.3.5. Recent Developments 21.3.3.6. Sales Footprint 21.3.3.7. Strategy Overview 21.3.3.7.1. Marketing Strategy 21.3.3.7.2. Product Type Strategy 21.3.3.7.3. Channel Strategy 21.3.4. Magellan Stem Cells 21.3.4.1. Overview 21.3.4.2. Product Type Portfolio 21.3.4.3. Analyst Commentary 21.3.4.4. Key Financials 21.3.4.5. Recent Developments 21.3.4.6. Sales Footprint 21.3.4.7. Strategy Overview 21.3.4.7.1. Marketing Strategy 21.3.4.7.2. Product Type Strategy 21.3.4.7.3. Channel Strategy 21.3.5. PrimeGen Biotech, LLC 21.3.5.1. Overview 21.3.5.2. Product Type Portfolio 21.3.5.3. Analyst Commentary 21.3.5.4. Key Financials 21.3.5.5. Recent Developments 21.3.5.6. Sales Footprint 21.3.5.7. Strategy Overview 21.3.5.7.1. Marketing Strategy 21.3.5.7.2. Product Type Strategy 21.3.5.7.3. Channel Strategy 21.3.6. Vetbiologics (U.S. Stem Cell, Inc.) 21.3.6.1. Overview 21.3.6.2. Product Type Portfolio 21.3.6.3. Analyst Commentary 21.3.6.4. Key Financials 21.3.6.5. Recent Developments 21.3.6.6. Sales Footprint 21.3.6.7. Strategy Overview 21.3.6.7.1. Marketing Strategy 21.3.6.7.2. Product Type Strategy 21.3.6.7.3. Channel Strategy 21.3.7. Boehringer Ingelheim 21.3.7.1. Overview 21.3.7.2. Product Type Portfolio 21.3.7.3. Analyst Commentary 21.3.7.4. Key Financials 21.3.7.5. Recent Developments 21.3.7.6. Sales Footprint 21.3.7.7. Strategy Overview 21.3.7.7.1. Marketing Strategy 21.3.7.7.2. Product Type Strategy 21.3.7.7.3. Channel Strategy 21.3.8. Cell Therapy Sciences 21.3.8.1. Overview 21.3.8.2. Product Type Portfolio 21.3.8.3. Analyst Commentary 21.3.8.4. Key Financials 21.3.8.5. Recent Developments 21.3.8.6. Sales Footprint 21.3.8.7. Strategy Overview 21.3.8.7.1. Marketing Strategy 21.3.8.7.2. Product Type Strategy 21.3.8.7.3. Channel Strategy 21.3.9. VETherapy Corporation 21.3.9.1. Overview 21.3.9.2. Product Type Portfolio 21.3.9.3. Analyst Commentary 21.3.9.4. Key Financials 21.3.9.5. Recent Developments 21.3.9.6. Sales Footprint 21.3.9.7. Strategy Overview 21.3.9.7.1. Marketing Strategy 21.3.9.7.2. Product Type Strategy 21.3.9.7.3. Channel Strategy 21.3.10. MediVet Biologics LLC (Ardent Animal Health) 21.3.10.1. Overview 21.3.10.2. Product Type Portfolio 21.3.10.3. Analyst Commentary 21.3.10.4. Key Financials 21.3.10.5. Recent Developments 21.3.10.6. Sales Footprint 21.3.10.7. Strategy Overview 21.3.10.7.1. Marketing Strategy 21.3.10.7.2. Product Type Strategy 21.3.10.7.3. Channel Strategy 21.3.11. Animal Cell Therapies, Inc. 21.3.11.1. Overview 21.3.11.2. Product Type Portfolio 21.3.11.3. Analyst Commentary 21.3.11.4. Key Financials 21.3.11.5. Recent Developments 21.3.11.6. Sales Footprint 21.3.11.7. Strategy Overview 21.3.11.7.1. Marketing Strategy 21.3.11.7.2. Product Type Strategy 21.3.11.7.3. Channel Strategy 21.3.12. Medrego 21.3.12.1. Overview 21.3.12.2. Product Type Portfolio 21.3.12.3. Analyst Commentary 21.3.12.4. Key Financials 21.3.12.5. Recent Developments 21.3.12.6. Sales Footprint 21.3.12.7. Strategy Overview 21.3.12.7.1. Marketing Strategy 21.3.12.7.2. Product Type Strategy 21.3.12.7.3. Channel Strategy 21.3.13. AniCell Biotech 21.3.13.1. Overview 21.3.13.2. Product Type Portfolio 21.3.13.3. Analyst Commentary 21.3.13.4. Key Financials 21.3.13.5. Recent Developments 21.3.13.6. Sales Footprint 21.3.13.7. Strategy Overview 21.3.13.7.1. Marketing Strategy 21.3.13.7.2. Product Type Strategy 21.3.13.7.3. Channel Strategy 22. Assumptions and Acronyms Used 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Product Type
Table 02: Global Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Source
Table 03: Global Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Application
Table 04: Global Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Species
Table 05: Global Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By End User
Table 06: Global Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Species Age Group
Table 07: Global Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Region
Table 08: North America Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 09: North America Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Product Type
Table 10: North America Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Application
Table 11: North America Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Source
Table 12: North America Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Species
Table 13: North America Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By End User
Table 14: Europe Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 15: Europe Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Product Type
Table 16: Europe Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Application
Table 17: Europe Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Source
Table 18: Europe Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Species
Table 19: Europe Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By End User
Table 20: Middle East and Africa Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 21: Middle East and Africa Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Product Type
Table 22: Middle East and Africa Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Application
Table 23: Middle East and Africa Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Source
Table 24: Middle East and Africa Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Species
Table 25: Middle East and Africa Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By End User
Table 26: Rest of the World Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Product Type
Table 27: Rest of the World Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Application
Table 28: Rest of the World Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Source
Table 29: Rest of the World Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Species
Table 30: Rest of the World Market Species (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034
Figure 02: Global Market Absolute $ Opportunity, 2024 to 2034
Figure 03: Global Market Share Analysis (%), By Product Type, 2024 & 2034
Figure 04: Global Market Y-o-Y Analysis (%), By Product Type, 2024 to 2034
Figure 05: Global Market Attractiveness Analysis By Product Type, 2024 to 2034
Figure 06: Global Market Share Analysis (%), By Source, 2024 & 2034
Figure 07: Global Market Y-o-Y Analysis (%), By Source, 2024 to 2034
Figure 08: Global Market Attractiveness Analysis By Source, 2024 to 2034
Figure 09: Global Market Share Analysis (%), By Application, 2024 & 2034
Figure 10: Global Market Y-o-Y Analysis (%), By Application, 2024 to 2034
Figure 11: Global Market Attractiveness Analysis By Application, 2024 to 2034
Figure 12: Global Market Share Analysis (%), By Species, 2024 & 2034
Figure 13: Global Market Y-o-Y Analysis (%), By Species, 2024 to 2034
Figure 14: Global Market Attractiveness Analysis By Species, 2024 to 2034
Figure 15: Global Market Share Analysis (%), By End User, 2024 & 2034
Figure 16: Global Market Y-o-Y Analysis (%), By End User , 2024 to 2034
Figure 17: Global Market Attractiveness Analysis, By End User, 2024 to 2034
Figure 18: Global Market Share Analysis (%), By Species Age Group, 2024 & 2034
Figure 19: Global Market Y-o-Y Analysis (%), By Species Age Group, 2024 to 2034
Figure 20: Global Market Attractiveness Analysis By Species Age Group, 2024 to 2034
Figure 21: Global Market Share Analysis (%), By Region, 2024 & 2034
Figure 22: Global Market Y-o-Y Analysis (%), By Region, 2024 to 2034
Figure 23: Global Market Attractiveness Analysis, By Region, 2024 to 2034
Figure 24: North America Market Value Share, By Product Type, 2024 (E)
Figure 25: North America Market Value Share, By Applications 2024 (E)
Figure 26: North America Market Value Share, By Source, 2024 (E)
Figure 27: North America Market Value Share, By Species, 2024 (E)
Figure 28: North America Market Value Share, By End User, 2024 (E)
Figure 29: North America Market Value Share, By Country, 2024 (E)
Figure 30: North America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034
Figure 31: North America Market Attractiveness Analysis By Product Type, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis By Application, 2024 to 2034
Figure 33: North America Market Attractiveness Analysis By Source, 2024 to 2034
Figure 34: North America Market Attractiveness Analysis By Species, 2024 to 2034
Figure 35: North America Market Attractiveness Analysis By End User, 2024 to 2034
Figure 36: North America Market Attractiveness Analysis By Country, 2024 to 2034
Figure 37: Europe Market Value Share, By Product Type, 2024 (E)
Figure 38: Europe Market Value Share, By Applications 2024 (E)
Figure 39: Europe Market Value Share, By Source, 2024 (E)
Figure 40: Europe Market Value Share, By Species, 2024 (E)
Figure 41: Europe Market Value Share, By End User, 2024 (E)
Figure 42: Europe Market Value Share, By Country, 2024 (E)
Figure 43: Europe Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034
Figure 44: Europe Market Attractiveness Analysis By Product Type, 2024 to 2034
Figure 45: Europe Market Attractiveness Analysis By Application, 2024 to 2034
Figure 46: Europe Market Attractiveness Analysis By Source, 2024 to 2034
Figure 47: Europe Market Attractiveness Analysis By Species, 2024 to 2034
Figure 48: Europe Market Attractiveness Analysis By Source, 2024 to 2034
Figure 49: Europe Market Attractiveness Analysis By Country, 2024 to 2034
Figure 50: Middle East and Africa Market Value Share, By Product Type, 2024 (E)
Figure 51: Middle East and Africa Market Value Share, By Application, 2024 (E)
Figure 52: Middle East and Africa Market Value Share, By Source, 2024 (E)
Figure 53: Middle East and Africa Market Value Share, By Species, 2024 (E)
Figure 54: Middle East and Africa Market Value Share, By End User, 2024 (E)
Figure 55: Middle East and Africa Market Value Share, By Country, 2024 (E)
Figure 56: Middle East and Africa Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034
Figure 57: Middle East and Africa Market Attractiveness Analysis By Product Type, 2024 to 2034
Figure 58: Middle East and Africa Market Attractiveness Analysis By Application, 2024 to 2034
Figure 59: Middle East and Africa Market Attractiveness Analysis By Source, 2024 to 2034
Figure 60: Middle East and Africa Market Attractiveness Analysis By Species, 2024 to 2034
Figure 61: Middle East and Africa Market Attractiveness Analysis By End User, 2024 to 2034
Figure 62: Middle East and Africa Market Attractiveness Analysis By Country, 2024 to 2034
Figure 63: Rest of the World Market Value Share, By Product Type, 2024 (E)
Figure 64: Rest of the World Market Value Share, By Applications 2024 (E)
Figure 65: Rest of the World Market Value Share, By Source, 2024 (E)
Figure 66: Rest of the World Market Value Share, By Species, 2024 (E)
Figure 67: Rest of the World Market Value Share, By End User, 2024 (E)
Figure 68: Rest of the World Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034
Figure 69: Rest of the World Market Attractiveness Analysis By Product Type, 2024 to 2034
Figure 70: Rest of the World Market Attractiveness Analysis By Application, 2024 to 2034
Figure 71: Rest of the World Market Attractiveness Analysis By Source, 2024 to 2034
Figure 72: Rest of the World Market Attractiveness Analysis By Species, 2024 to 2034
Figure 73: Rest of the World Market Attractiveness Analysis By End User, 2024 to 2034
Figure 74: United States Market Value Share, By Product Type, 2024 & 2034
Figure 75: United States Market Value Share, By Application, 2024 & 2034
Figure 76: United States Market Value Share, By Source, 2024 & 2034
Figure 77: United States Market Value Share, By Species Age Group, 2024 & 2034
Figure 78: United States Market Value Share, By End User, 2024 & 2034
Figure 79: United States Market Value Analysis (US$ Mn), 2024 & 2034
Figure 80: Canada Market Value Share, By Product Type, 2024 & 2034
Figure 81: Canada Market Value Share, By Application, 2024 & 2034
Figure 82: Canada Market Value Share, By Source, 2024 & 2034
Figure 83: Canada Market Value Share, By Species Age Group, 2024 & 2034
Figure 84: Canada Market Value Share, By End User, 2024 & 2034
Figure 85: Canada Market Value Analysis (US$ Mn), 2024 & 2034
Figure 86: United Kingdom Market Value Share, By Product Type, 2024 & 2034
Figure 87: United Kingdom Market Value Share, By Application, 2024 & 2034
Figure 88: United Kingdom Market Value Share, By Source, 2024 & 2034
Figure 89: United Kingdom Market Value Share, By Species Age Group, 2024 & 2034
Figure 90: United Kingdom Market Value Share, By End User, 2024 & 2034
Figure 91: United Kingdom Market Value Analysis (US$ Mn), 2024 & 2034
Figure 92: Germany Market Value Share, By Product Type, 2024 & 2034
Figure 93: Germany Market Value Share, By Application, 2024 & 2034
Figure 94: Germany Market Value Share, By Source, 2024 & 2034
Figure 95: Germany Market Value Share, By Species Age Group, 2024 & 2034
Figure 96: Germany Market Value Share, By End User, 2024 & 2034
Figure 97: Germany Market Value Analysis (US$ Mn), 2024 & 2034
Figure 98: France Market Value Share, By Product Type, 2024 & 2034
Figure 99: France Market Value Share, By Application, 2024 & 2034
Figure 100: France Market Value Share, By Source, 2024 & 2034
Figure 101: France. Market Value Share, By Species Age Group, 2024 & 2034
Figure 102: France Market Value Share, By End User, 2024 & 2034
Figure 103: France Market Value Analysis (US$ Mn), 2024 & 2034
Figure 104: Italy Market Value Share, By Product Type, 2024 & 2034
Figure 105: Italy Market Value Share, By Application, 2024 & 2034
Figure 106: Italy Market Value Share, By Source, 2024 & 2034
Figure 107: Italy Market Value Share, By Species Age Group, 2024 & 2034
Figure 108: Italy Market Value Share, By End User, 2024 & 2034
Figure 109: Italy Market Value Analysis (US$ Mn), 2024 & 2034
Figure 110: Spain Market Value Share, By Product Type, 2024 & 2034
Figure 111: Spain Market Value Share, By Application, 2024 & 2034
Figure 112: Spain Market Value Share, By Source, 2024 & 2034
Figure 113: Spain Market Value Share, By Species Age Group, 2024 & 2034
Figure 114: Spain Market Value Share, By End User, 2024 & 2034
Figure 115: Spain Market Value Analysis (US$ Mn), 2024 & 2034
Figure 116: GCC Countries. Market Value Share, By Product Type, 2024 & 2034
Figure 117: GCC Countries Market Value Share, By Application, 2024 & 2034
Figure 118: GCC Countries Market Value Share, By Source, 2024 & 2034
Figure 119: GCC Countries Market Value Share, By Species, 2024 & 2034
Figure 120: GCC Countries Market Value Share, By End User, 2024 & 2034
Figure 121: GCC Countries Market Value Analysis (US$ Mn), 2024 & 2034
Figure 122: South Africa Market Value Share, By Product Type, 2024 & 2034
Figure 123: South Africa Market Value Share, By Application, 2024 & 2034
Figure 124: South Africa Market Value Share, By Source, 2024 & 2034
Figure 125: South Africa Market Value Share, By Species Age Group, 2024 & 2034
Figure 126: South Africa Market Value Share, By End User, 2024 & 2034
Figure 127: South Africa Market Value Analysis (US$ Mn), 2024 & 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the expected value of the animal stem cell therapy market in 2024?
The global animal stem cell therapy market is calculated at US$ 290.5 million for 2024.
What is the projected sales value of animal stem cell therapies by 2034?
Revenue from animal stem cell therapy is forecasted to reach US$ 474.8 million by 2034-end.
At what rate is the demand for stem cell therapies projected to rise?
Global demand for animal stem cell therapies is projected to increase at a CAGR of 5% from 2024 to 2034.
Which type of animal stem cell therapy is in high demand?
Demand for mesenchymal stem cell-based therapy is set to increase at a CAGR of 5.2% through 2034.
Which are the two main types of stem cells?
The two types of stem cells are hematopoietic stem cells and mesenchymal stem cells.
Animal Stem Cell Therapy Market